Search - tctmd.com

Displaying 581 - 600 of 638

Sort: Relevancy | Date

News Daily News

Obesidad Mórbida: Un Factor de Riesgo, en Aumento, en Pacientes con PCI

L.A. McKeown

June 20, 2013

News Daily News

Morbid Obesity: An Increasing Risk Factor in PCI Patients

L.A. McKeown

June 20, 2013

News Daily News

La Respuesta Antiplaquetaria de los Afroamericanos Desfavorecida por una Variante Genética, la ‘Raza’

June 07, 2013

News Daily News

African Americans’ Antiplatelet Response Handicapped by Gene Variant, ‘Race’

June 07, 2013

News Daily News

Nonsystem Delays in STEMI Patients Predict In-Hospital Mortality

Yael L. Maxwell

April 19, 2013

News Daily News

Mortality Varies by Revascularization Method in Dialysis Patients

Caitlin E. Cox

April 19, 2013

News Daily News

Los Retrasos Fuera del Sistema en Pacientes STEMI Predicen la Mortalidad intra-Hospitalaria

Yael L. Maxwell

April 19, 2013

News Daily News

La Mortalidad Varía según el Método de Revacularización en Pacientes a Diálisis

Caitlin E. Cox

April 19, 2013

News Daily News

Los Pacientes Negros son Más Propensos a Sufrir Amputaciones en presencia de Isquemia Crítica de las Extremidades

March 28, 2013

News Daily News

Black Patients More Likely to Undergo Amputation for Critical Limb Ischemia

March 28, 2013

News Daily News

Morbid Obesity Lowers In-Hospital Mortality in AMI Patients

Jason Kahn

February 14, 2013

News Daily News

La Obesidad Mórbida Reduce la Mortalidad intra Hospitalaria en Pacientes víctimas de IAM

Jason Kahn

February 14, 2013

News Daily News

TEVAR Alleviates Racial Disparity for Thoracic Aneurysm Repair

L.A. McKeown

December 16, 2012

News Daily News

La TEVAR Alivia la Disparidad Racial en la Reparación del Aneurisma Torácico

L.A. McKeown

December 16, 2012

News Industry News

Analysis Of Medtronic Stent Finds Early Cessation Of Dual Antiplatelet Therapy Caused No Increased Risk Of Blood Clots To One Year

October 22, 2012

News Daily News

New Class of Oral Anticoagulants Safer Compared with Warfarin for A-fib

October 19, 2012

News Industry News

Medtronic Initiates First Clinical Trial of the Symplicity™ Renal Denervation System for Treatment-Resistant Hypertension in Japan

October 01, 2012

News Daily News

Un Modelo Sugiere que la Denervación Renal es Rentable contra la Hipertensión Resistente

September 13, 2012

News Daily News

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

September 13, 2012

News Industry News

Health-Economic Analysis Suggests Medtronic Symplicity™ Renal Denervation System Is Cost-Effective and May Reduce Cardiovascular Event Risks for Patients with Treatment-Resistant Hypertension

September 12, 2012

Advertisement

Obesidad Mórbida: Un Factor de Riesgo, en Aumento, en Pacientes con PCI

Morbid Obesity: An Increasing Risk Factor in PCI Patients

La Respuesta Antiplaquetaria de los Afroamericanos Desfavorecida por una Variante Genética, la ‘Raza’

African Americans’ Antiplatelet Response Handicapped by Gene Variant, ‘Race’

Nonsystem Delays in STEMI Patients Predict In-Hospital Mortality

Mortality Varies by Revascularization Method in Dialysis Patients

Los Retrasos Fuera del Sistema en Pacientes STEMI Predicen la Mortalidad intra-Hospitalaria

La Mortalidad Varía según el Método de Revacularización en Pacientes a Diálisis

Los Pacientes Negros son Más Propensos a Sufrir Amputaciones en presencia de Isquemia Crítica de las Extremidades

Black Patients More Likely to Undergo Amputation for Critical Limb Ischemia

Morbid Obesity Lowers In-Hospital Mortality in AMI Patients

La Obesidad Mórbida Reduce la Mortalidad intra Hospitalaria en Pacientes víctimas de IAM

TEVAR Alleviates Racial Disparity for Thoracic Aneurysm Repair

La TEVAR Alivia la Disparidad Racial en la Reparación del Aneurisma Torácico

Analysis Of Medtronic Stent Finds Early Cessation Of Dual Antiplatelet Therapy Caused No Increased Risk Of Blood Clots To One Year

New Class of Oral Anticoagulants Safer Compared with Warfarin for A-fib

Medtronic Initiates First Clinical Trial of the Symplicity™ Renal Denervation System for Treatment-Resistant Hypertension in Japan

Un Modelo Sugiere que la Denervación Renal es Rentable contra la Hipertensión Resistente

Model Suggests Renal Denervation Cost-effective for Resistant Hypertension

Health-Economic Analysis Suggests Medtronic Symplicity™ Renal Denervation System Is Cost-Effective and May Reduce Cardiovascular Event Risks for Patients with Treatment-Resistant Hypertension

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content